Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Japan, South Korea fret as surging coronavirus undermines leaders' support

Published 12/14/2020, 01:26 AM
Updated 12/14/2020, 08:07 AM
© Reuters. FILE PHOTO: People shop amid the coronavirus disease (COVID-19) pandemic at a traditional market in Seoul

By Rocky Swift and Sangmi Cha

TOKYO/SEOUL (Reuters) - Japan and South Korea grappled with surging coronavirus cases and growing public frustration on Monday, with Japan suspending a contentious travel subsidy programme and South Korea closing some schools and considering its toughest curbs yet.

Japan reported more than 3,000 new cases on Saturday, yet another record as winter set in, with infections worsening in Tokyo, the northern island of Hokkaido and the city of Osaka.

But Japan, with a focus on the economic costs, has steered clear of tough lockdowns. It tackled its first wave of infections in the spring by asking people to refrain from going out and for businesses to close or curtail operating hours.

The government also launched a subidy programme called "Go To Travel" to encourage domestic tourism and support businesses but critics said encouraging people to travel had helped spread infections.

Prime Minister Yoshihide Suga had ruled out halting the programme, citing economic considerations, but that changed after weekend polls showed his support being eroded over his handling of the pandemic.

The programme would be suspended nationwide for two weeks from Dec. 28, media reported.

Across the sea in South Korea, President Moon Jae-in also faces sliding ratings as clusters of new infections fuel criticism over what many see as slack containment.

Moon has warned of the possibility more stringent curbs.

"Our back is against the wall," he said. "This is a crucial moment to devote all our virus control capabilities and administrative power to stopping the coronavirus."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

South Korea reported a new daily record of 1,030 infections on Sunday, a big worry for a country for months held up as a mitigation success story but still a fraction of the tallies being seen in some European countries and the United States, where vaccines are being rolled out.

Few Asian countries expect to get significant amounts of coronavirus vaccines in coming weeks as they manage distribution schedules, allow time to check for any inoculation side effects elsewhere or run their own late-stage trials.

Instead, they are counting on the methods that have largely kept infections in check for months - ahead of the curve testing, stringent travel curbs, strict social distancing and masks.

SOME GOOD NEWS

China, for instance, where the virus emerged almost a year ago, has managed to limit new cases with tough, sweeping action.

It locked down an area of more than 250,000 people after half a dozen cases were confirmed near the Russian border in the province of Heilongjiang, the Associated Press reported on Monday.

Singapore, which has reported only a handful of local cases over the past two months, said it was easing restrictions and would soon allow up to eight people to gather. It also approved Pfizer-BioNTech's vaccine and said it expected its first shots by the end of the month.

New Zealand, which has been particularly successful in tackling the pandemic, said it had agreed to open a "travel bubble" with Australia in the first quarter of 2021.

South Korea ordered schools to close in its capital, Seoul, and surrounding areas and warned that restrictions may be raised to the highest Phase 3 level, which would essentially mean a lockdown for the first time in Asia's fourth-largest economy.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Last month, the government banned year-end parties and it has ramped up testing to more than 22,000 people a day, compared with about 16,000 a day in September.

In Japan, which is hoping to stage the postponed summer Olympics next year, testing has remained relatively low, peaking at about 50,000 in one day recently. Testing in Tokyo, which has the capacity for more than 60,000, is now about 9,000 a day.

"Whether a country or region is doing enough testing should be assessed based on the positivity rate and not on the number of tests," said Fumie Sakamoto, infection control manager at the St Luke's International Hospital in Tokyo.

"The positivity rate for Tokyo is now over 6%, so we should be doing a bit more testing to bring the number down."

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

FACTBOX-When and which COVID-19 vaccines are likely to be available in Asia

FACTBOX-Worldwide coronavirus cases cross 71.12 million, death toll at 1,608,412

Interactive graphic tracking global spread of coronavirus (open in external browser) https://tmsnrt.rs/2FThSv7

Case tracker for Eikon users https://apac1.apps.cp.thomsonreuters.com/cms/?navid=1063154666

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.